药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Tazarotene
Blinatumomab
The risk or severity of adverse effects can be increased when Arsenic trioxide is combined with Blinatumomab.
Tazarotene
Siltuximab
The risk or severity of adverse effects can be increased when Arsenic trioxide is combined with Siltuximab.
Tazarotene
Vedolizumab
The risk or severity of adverse effects can be increased when Arsenic trioxide is combined with Vedolizumab.
Tazarotene
Secukinumab
The risk or severity of adverse effects can be increased when Arsenic trioxide is combined with Secukinumab.
Tazarotene
Fluprednidene
The risk or severity of adverse effects can be increased when Arsenic trioxide is combined with Fluprednidene.
Tazarotene
Obinutuzumab
The risk or severity of adverse effects can be increased when Arsenic trioxide is combined with Obinutuzumab.
Tazarotene
Pomalidomide
The risk or severity of adverse effects can be increased when Arsenic trioxide is combined with Pomalidomide.
Tazarotene
Dimethyl fumarate
The risk or severity of adverse effects can be increased when Arsenic trioxide is combined with Dimethyl fumarate.
Tazarotene
Fluticasone furoate
The risk or severity of adverse effects can be increased when Arsenic trioxide is combined with Fluticasone furoate.
Tazarotene
Certolizumab pegol
The risk or severity of adverse effects can be increased when Arsenic trioxide is combined with Certolizumab pegol.
Tazarotene
Ponatinib
The risk or severity of adverse effects can be increased when Arsenic trioxide is combined with Ponatinib.
Tazarotene
Carfilzomib
The risk or severity of adverse effects can be increased when Arsenic trioxide is combined with Carfilzomib.
Tazarotene
Teriflunomide
The risk or severity of adverse effects can be increased when Arsenic trioxide is combined with Teriflunomide.
Tazarotene
Belimumab
The risk or severity of adverse effects can be increased when Arsenic trioxide is combined with Belimumab.
Tazarotene
Ruxolitinib
The risk or severity of adverse effects can be increased when Arsenic trioxide is combined with Ruxolitinib.
Tazarotene
Eribulin
The risk or severity of adverse effects can be increased when Arsenic trioxide is combined with Eribulin.
Tazarotene
Brentuximab vedotin
The risk or severity of adverse effects can be increased when Arsenic trioxide is combined with Brentuximab vedotin.
Tazarotene
Wortmannin
The risk or severity of adverse effects can be increased when Arsenic trioxide is combined with Wortmannin.
Tazarotene
Pralatrexate
The risk or severity of adverse effects can be increased when Arsenic trioxide is combined with Pralatrexate.
Tazarotene
Cabazitaxel
The risk or severity of adverse effects can be increased when Arsenic trioxide is combined with Cabazitaxel.